Article

Vaccine candidates, immuno-dominant antigens, and potent vaccine adjuvants for preventing cutaneous leishmaniasis: a sys

2024-06-14

Abstract excerpt

<h4>Background: </h4> Cutaneous leishmaniasis (CL) is the most common clinical form of leishmaniasis that causes skin disease. Currently, there is no licensed prophylactic vaccine for CL, as the mechanisms of healing and memory T-cell responses that develop after infection with CL are far from fully understood. A review of the published articles identifying CL vaccine candidates, immuno-dominant antigens, and pote...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2e7a4dbe-4528-5246-b44c-e4ca108cd395
DOI: 10.22541/au.171836774.40365955/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Vaccine candidates, immuno-dominant antigens, and potent vaccine adjuvants for preventing cutaneous leishmaniasis: a sysDOI 10.22541/au.171836774.40365955/v1Read

In silico designing of a novel polyvalent multi-subunit peptide vaccine leveraging cross- immunity against human visceral & cutaneous leishmaniasis: An Immunoinformatics-based approachSemantic proximity Read

Immunogenicity Evaluation of a Novel Lentiviral Vaccine Expressing Multi- Epitope Against of Leishmania Major in BALB/c MiceSemantic proximity Read

A T-Cell Epitope-Based Multi-Epitope Vaccine Designed Using Human HLA Specific T Cell Epitopes Induces Sterile Immunity against Experimental Visceral Leishmaniasis in HamstersSemantic proximity Read

Designing of a new multi-epitope vaccine against Leishmania major using Leish-F1 epitopes: An In-silico studySemantic proximity Read

Unraveling the Immune Response Dynamics of Leishmaniasis: Insights, Challenges, and Vaccine DevelopmentSemantic proximity Read

Design of a multi-epitope subunit vaccine for immune-protection against Leishmania parasiteSemantic proximity Read

Multi-epitope vaccine design against leishmaniasis using IFN-γ inducing epitopes from immunodominant gp46 and gp63 proteinsSemantic proximity Read

Adjuvantation of whole-killed Leishmania vaccine with anti-CD200 and anti-CD300a antibodies potentiates its efficacy and provides strong protection against virulent parasitesSemantic proximity Read

Leishmaniasis: Current Status of Vaccine DevelopmentSemantic proximity Read

Immune Responses in Leishmaniasis: An OverviewSemantic proximity Read

Intradermal Synthetic DNA Vaccination Generates Leishmania -Specific T Cells in the Skin and Protection against Leishmania majorSemantic proximity Read

<i>Leishmania</i>vaccines: progress and problemsSemantic proximity Read